Monoclonal gammopathies antigen driven in autoimmune diseases

Clinical and Experimental Rheumatology

Volumn 14, Issue SUPPL. 14, 1996, Pages

  Osterland, C K ^a,b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

autoantibodies; B lymphocyte clonal growth; monoclonal gammopathies

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNITY; B LYMPHOCYTE; CONFERENCE PAPER; HUMAN; LYMPHOCYTE CLONE; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CLONE CELLS; HUMANS; PARAPROTEINEMIAS;

EID: 0030005167     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. DE VITA S, FERRACCIOLI GF, DE RE V et al.: The polymerase chain reaction detects B cell clonalities in patients with Sjögren's syndrome and suspected malignant lymphoma. J Rheumatol 1994; 21: 1497-1501.
2. LEACH IH, JENKINS J, MURRAY-LESLIE CF, POWELL RJ: μ-heavy chain and monoclonal IgGK paraproteins in systemic lupus. Br J Rheumatol 1987; 26: 460-2.
3. HURST NP, SMITH W, HENDERSON D: IgG(K) paraproteinemia and arthritis. Br J Rheumatol 1987; 26: 142-6.
4. HARDIMAN RL, HORN S, MANOHARAN D, PHADKE K, GIBSON J, MCGUIGAN L, STURGESS A: Rheumatic auto antibodies in sera of patients with paraproteins. Arthritis Rheum 1994; 12: 363-8.
5. VITALI C, BAGLIONI P, VIVALDI I, CACIALLI R, TAVONI A, BOMBARDIERI S: Erosive arthritis in monoclonal gammopathy of uncertain significance: report of four cases. Arthritis Rheum 1991; 34: 1600-5.
6. OSTERLAND CK: Monoclonal gammopathies. Their identification and biological significance. Clinica ChimicaActa 1989; 180: 1-22.
7. SELIGMAN M, BROUET JC: Antibody activities of human monoclonal immunoglobulins. Clinical Immunol Newsletter 1986; 7: 129-32.
8. CROUZIER R, MARTIN T, PASQUALI JL: Monoclonal IgM RF secreted by CD-5 negative B-cells during mixed cryoglobulinemia. J Immunol 1995; 154: 413-21.
9. SELA O, SHOENFELD Y: Cancer in autoimmune diseases. Semin Arthritis Rheum 1988; 18: 77-87.
10. SESTAK A, HARLEY J, YOSHIDA S, REICHLIN M: Lupus/ Sjögren's auto antibody in sera with paraproteins. J Clin Invest 1987; 80: 138-44.
11. SHOKRI F, MAGEED R, MAZIAK R, TALAL N, AMOS N, WILLIAMS B, JEFFERIS R: Lymphoproliferation in primary Sjögren's syndrome: Selective expansion of B-cell subsets. Arthritis Rheum 1993; 36: 1128-35.
12. ABBAS AK, MOSER C: Idiotypic suppression of B-cell derived tumors. In: GREENE M, NISONOFF A (Eds): Biology of Idiotypes. Plenum Press, 1984; 315-25.
13. EISEN HN, LITTLE JR, OSTERLAND CK: A myeloma protein with antibody activity. Cold Spring Harbour Symposum on Quantitative Biology. 1967; 32: 75-87.
14. DAVIS TH, YOCKEY C, BALK S: Detection of clonal Ig gene rearrangement by PCR and single strand conformational polymorphism. Am JPath 1993; 442: 1841.
15. BILLADEAU D, GREIFF P, AHMANN G, WITZIG T, VAN NESS B: Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS. Current Topics in Microbiology and Immunology 1994; 194: 9-16.
16. HARRISON H, MILLER K, ABU-ALFA A, PODLASEK J: Immunoglobulin clonality analysis. Am J Clin Path 1993; 100: 550-60.
17. MIGLINO M, GAETANI G, CANEPA L, MELONI T, FORTELEONI G, FERRARIS AM: Molecular analysis of clonality in plasma cell dyscrasias. Br J Haematol 1992; 81: 18-22.
18. MERICO F, BERGUI L, GREGORETTI M, GHLA P, AIMS G, LINDLEY I, CALIGARISCAPPIO F: Role of cytokines in progression of multiple myeloma. Clin Exp Immunol 1993; 92: 27-32.
19. LUST JA: Role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clin Proc 1995; 69: 691-7.
20. CALIGARIS-CAPPIO F, BERGUI L, GAIDANO G, MERICO F, SCHENA M: In vitro studies provide evidence that multiple paracrine loops may be operating in multiple myeloma. In OBRAMS G, POTTER M (Eds): Epidemiology and Biology of Multiple Myeloma. Springer-Verlag 1991; 123-7.
21. EPSTEIN J, HATA H: Multiple myeloma evolves from a malignant hematopoietic stem cell. In OBRAMS GI, POTTER M (Eds.): Epidemiology and Biology of Multiple Myeloma. Springer-Verlag 1991; 142-4.
22. KYLE RA: "Benign" monoclonal gammopathy - after 20 - 35 year follow-up: Mayo Clinic Proc 1993; 68: 26-36.
23. RADL J: The mouse model of B cell proliferative disorders. Relationship between benign monoclonal gammopathy and multiple myeloma. In: OBRAMS G, POTTER M (Eds.): Epidemiology and Biology of Multiple Myeloma. Springer-Verlag 1991; 161-5.
24. PORTIER M, MOLES JP, MAZARS G, JEANTEUR P, BATAILLE R, KLEIN B: p.53 and RAS gene mutations in multiple myeloma. Oncogene 1992; 7: 2539-43.
25. HARADA H, KAWANO M, HUANG N, HARADA Y, IWATO K, TANABE O, TANAKA H, SAKAI A, ASAOKU H, KURAMATO A: Phenotypic differences between normal plasma cells and myeloma cells. Blood 1993; 2658-63.
26. OSTERLAND CK, MILLER EJ, KARAKAWA W, KRAUSE RM: Characteristics of streptococcal group-specific antibody isolated from hyperimmune rabbits. J Exp Med 1966; 123: 599-613.
27. KANTOR AB: The development and repertoire of CD5+ B cells. Immunol Today 1991; 12: 389-91.
28. FFRENCH M, FFRENCH P. REMY F et al: Plasma cell proliferation in monoclonal gammopathy - diagnostic and prognostic significance. Am J Med 1995; 98: 60-5.
29. PELICCI P, KNOWLES D, ARLIN Z: Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in AIDS related lymphomas. J Exp Med 1986; 164: 2049-60.
30. PAPADOPOULOS N, LANE HC, COSTELLO R, MOUTSOPOULOS H, MASUR H, GALMAN E, FAUCI AS: Oligoclonal immunoglobulins in patients with AIDS. Clin Immunol Immunopath 1985; 35: 45-50.
31. HOCHBERG M, SHULMAN L: Acute leukemia following cyclophosphamide for Sjögren's syndrome. Johns Hopkins Med J 1978; 142: 211-4.
32. JENSEN G, MANT M, BELCH A, RUETHER B, PILARSKI L: CD45 isoforms on CALLA+ B cells in the peripheral blood of multiple myeloma patients. Blood 1991; 78: 711-7.
33. RADL J: Age related monoclonal gammopathies. Immunology Today 1990; 11: 234-6.
34. CLASSEN JB, SHEVACH S: Post-thymectomy organ specific A-I: enhancement by cycloporine and inhibition by IL-2. Autoimmunity 1993; 15: 55-9.